FDA Approves Ingestible Digital Sensor that Tracks Medication Adherence | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

FDA Approves Ingestible Digital Sensor that Tracks Medication Adherence

August 2, 2012
by Gabriel Perna
| Reprints

The U.S. Food and Drug Administration (FDA) has approved of an ingestible digital sensor that is used to transmit patient data to track medication adherence, according to a press release from the company that is marketing the device. The company, Redwood City, Calif.-based Proteus Digital Health, Inc., announced that the ingestible sensor, referred to as the Ingestion Event Marker, has been approved by the FDA after the company worked with the agency for several years to determine a regulatory pathway.

“We are thrilled to have achieved this important milestone to market our ingestible sensor in the United States now, as well as in Europe,” Dr. George M. Savage, co-founder and chief medical officer at Proteus Digital Health, said in a statement. “We are very much looking forward to bringing the benefits of our ingestible sensor to the American public in the form of innovative product offerings.”

The device, which is a part of the Proteus digital health feedback system that aims to improve patients’ health habits and connections to caregivers, is already approved in Europe. The pill is as small as a grain of sand and can be integrated into an inert pill or other ingested products, such as pharmaceuticals. According to Proteus, once the sensor reaches the stomach, it is powered by contact with stomach fluid and communicates a unique signal that determines identity and timing of ingestion.

The information is then transferred through the user’s body tissue to a patch worn on the skin, which detects the signal and marks the precise time an ingestible sensor has been taken, Proteus says. It relays the information to a mobile phone app. This is all done with the patient’s permission. Cost has not yet been determined.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).